Shuibing Chen   Professor of Chemical Biology in Surgery

Phone
  • +1 212 746 5423

The major research interest in the Chen Laboratory is to manipulate stem cell fate using chemical and biological approaches and to generate functional tissues and organs that can be used for translational research. Our current main focus is on human pluripotent stem cells (PSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). We combine our knowledge of stem cell biology, developmental biology, chemical biology, medicine chemistry and tissue engineering to derive functional cells, tissues and organs from human pluripotent stem cells. Our long-term goal is to apply patient specific PSC-derived tissues or organs for replacement therapy and build up “disease in a dish” platforms for drug discovery.

Dr. Chen is a faculty member in the Tri-Institutional PhD Program in Chemical Biology.

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

Background

Contact

full name

  • Shuibing Chen

primary email

  • shc2034@med.cornell.edu

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Consultant refers to an individual who provides expert advice to a business or entity (e.g., consulting on medical devices or pharmaceuticals)Consultant:
    Vesalius Therapeutics
    Ownership refers to any financial stake an individual owns in any company (e.g., stock options, equity interest)Ownership:
    Oncobeat, LLC